An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”
From the September 29th 2012 edition
Discover stories from this section and more in the list of contents
Explore the edition
A flight from the dollar could wreck America’s finances
The currency’s dominance enables very high debts and deficits, meaning a plunge might spell disaster
Investors realise Trump’s pause was not the salvation it appeared
As China strikes back, reality sets in
Can China fight America alone?
The world’s two biggest economies begin an almighty trade clash
The tariff madness of King Donald, explained
As his policy turns on a dime, pity those tasked with justifying his actions
China has a weapon that could hurt America: rare-earth exports
It has only just begun to use it
America’s financial system came close to the brink
Chaotic markets threatened to trigger a full-blown crisis